Drug Discovery World

OCTOBER 18, 2022

Dr Stephan Emmerth and Paul Eschmann, Basel Area Business & Innovation, explain the benefits of being based in Basel – the talent pool, global players, academic institutions and investors, for example. . An international business hub. and startups to multinational corporations – covering a range of industries. .

Life Science 52

Life Science Engineer Research Clinical Trials 52

The Pharma Data

DECEMBER 15, 2020

NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the U.S. Approval demonstrates our ability to execute upon the entirety of the drug development and registration process.

FDA Approval 52

FDA Approval Development Production Marketing 52

XTalks

AUGUST 2, 2023

In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. The order of the companies presented in this article is based on their 2022 full year or fiscal year revenue. billion in 2022, a 23.43 billion, a 42.74

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Drug Discovery World

AUGUST 4, 2022

Susan A Darling, Senior Director, CE and Biopharma, SCIEX and Todd Stawicki, Senior Global Marketing Manager, Biopharma, SCIEX examine advanced analytical technologies can help ensure that biopharma candidates are commercialisable. There are many different technologies for describing different properties of protein biomolecules.

Development 52

Development Protein Manufacturing Drugs 52

Drug Discovery World

JANUARY 23, 2024

This article is sponsored by Sphere Fluidics. The Sphere Fluidics team are excited to be attending SLAS2024 in Boston and invite delegates to visit their stand in the Exhibition Hall to discover their pioneering single cell discovery and analysis technology. The consortium has been awarded €3.4 The consortium has been awarded €3.4

Compliance 52

Compliance Production Development Packaging 52

The Pharma Data

NOVEMBER 24, 2020

24, 2020– Alnylam Pharmaceuticals, Inc. Oxlumo marks our third FDA approval in less than three years, positioning us to meet or exceed our Alnylam 2020 strategy and goals, and further highlighting the productivity of our RNAi platform and the speed at which we can bring innovative medicines to patients.

FDA Approval 52

FDA Approval Production RNA Medicine 52